查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1965427

近视和老花眼治疗市场－全球产业规模、份额、趋势、机会和预测：按近视治疗类型、老花眼治疗类型、地区和竞争格局划分，2021-2031年

Myopia And Presbyopia Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Myopia Treatment Type, By Presbyopia Treatment Type, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球近视和老花眼治疗市场预计将从 2025 年的 219.5 亿美元大幅成长到 2031 年的 353.8 亿美元，复合年增长率为 8.28%。

该行业涵盖多种矫正视力解决方案，包括处方眼镜、隐形眼镜、屈光矫正手术以及用于矫正近视和老龄化视力下降的药物。该行业的成长主要受人口结构变化驱动，例如全球人口老化以及与生活方式因素（如电子设备使用增加和户外活动减少）相关的近视盛行率上升。此外，人们对摆脱眼镜依赖的强烈潜在需求也大力推动了现代矫正技术的普及。例如，隐形眼镜研究所2024年的数据显示，47.8%从未尝试过隐形眼镜的眼镜配戴者对隐形眼镜表现出浓厚的兴趣，这表明隐形眼镜市场具有巨大的渗透潜力。

市场概览
预测期 2027-2031
市场规模：2025年 219.5亿美元
市场规模：2031年 353.8亿美元
复合年增长率：2026-2031年 8.28%
成长最快的细分市场 处方笺
最大的市场 北美洲

然而，尤其是在新兴经济体，由于先进矫正治疗费用高且供应有限，人们获得这些治疗存在许多障碍。高品质的屈光矫正手术和专用治疗设备需要大量投资，这限制了其普及，使其主要面向富裕人群，并阻碍了医疗基础设施不足的发展中地区的成长。因此，儘管存在需求，但经济壁垒阻碍了这些市场的扩张。

市场驱动因素

全球近视和老花眼盛行率的不断上升正在从根本上改变治疗格局，并成为市场成长的主要驱动力。这一激增与快速都市化和过度使用电子设备等生活方式因素密切相关，加速了年轻一代屈光不正的发生。因此，人们越来越迫切地需要超越传统矫正眼镜的有效管理策略，这促使了专用控制镜片和介入疗法的出现。为了因应这项重大的公共卫生挑战，英国验光师协会在2024年10月发表的报导《检验近视的全球蔓延》中指出，研究人员估计目前全球儿童和青少年近视盛行率为30.47%。这一数字敦促製造商加快创新步伐。

同时，新型药物疗法和矫正眼药水的出现，患者照护带来了革命性的变革，为手术和眼镜提供了非侵入性的替代方案。近期老花眼矫正眼药水和低剂量阿托品近视眼药水的商业化，标誌着视力障碍药物治疗领域的一次重大转变，而大量资金的流入也为这些解决方案的商业化提供了支持。例如，《验光时报》在2024年10月报道称，Orasis Pharmaceuticals公司已获得7,800万美元的资金筹措，用于支持其眼药水「Qlosi」的商业化。这种强劲的投资环境凸显了该产业的财务活力，而美国视觉委员会的一份报告显示，2024年美国光学产业的总市值达到了683亿美元。

市场挑战

先进正畸治疗的高昂费用和有限的普及程度是全球市场扩张的主要障碍。昂贵的屈光矫正手术和特殊药物带来的高昂经济门槛，使得这些解决方案仅限于富裕人群。这种经济差距阻碍了大众市场，尤其是在开发中国家，从传统的低成本矫正方法（例如普通眼镜）过渡到先进矫正治疗。因此，儘管先进正畸治疗具有临床益处，但由于绝大多数患者无力承担现代治疗所需的高额自付费用，其潜在市场规模被人为地限制了。

选择性手术的高昂费用加剧了这项挑战，因为这些费用通常不在综合保险的覆盖范围内。根据屈光矫正手术)的数据，2024 年双眼 LASIK 雷射近视手术的平均费用约为 4,400 美元。如此高昂的价格在新兴经济体中构成了一大障碍，因为这些地区的居民可支配收入有限，医疗基础设施往往不足以支持广泛获得这些专业治疗。因此，这些高成长地区的市场渗透率仍然缓慢，阻碍了整个行业的整体收入成长。

市场趋势

新一代近视控制眼镜镜片的普及，正在为儿童患者建立一种超越传统单焦点矫正的新治疗标准。这些先进的镜片采用特殊的光学散焦技术，能够主动抑制眼球伸长，这与仅矫正屈光不正的普通眼镜截然不同。临床证据证实了其有效性，推动了这一转变，并加速了其作为主要非侵入性干预手段的普及。这些产品的商业性成功凸显了其在治疗方案中日益增长的重要性。根据依视路陆逊梯卡集团于2025年2月发布的2024年第四季/全年新闻稿，其在中国的立体镜片销量在第四季度增长了约50%。

同时，植入式胶原蛋白晶体（ICL）技术的进步正不断扩大，成为高度近视患者（不适合接受角膜雷射手术）的一种手术选择。这反映了技术从LASIK等减法手术转向能够保护角膜完整性的加法手术的转变。製造商透过扩大这些医疗设备的屈光矫正范围，提高了外科医师的信心和病患的接受度。随着手术数量的增加，该行业取得了强劲的财务业绩。根据STAAR Surgical于2025年10月发布的题为「STAAR Surgical公布2025年第三季初步净销售额」的新闻稿，该公司初步净销售额为9,470万美元，年增6.9%。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：近视与老花眼治疗的全球市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 近视治疗方法（矫正、手术和药物）
    • 老花眼治疗方法（处方笺、隐形眼镜、人工水晶体、屈光矫正手术）
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美近视与老花眼治疗市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲近视与老花眼治疗市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区近视与老花眼治疗市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲近视和老花眼治疗市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美洲近视与老花眼治疗市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章 全球近视与老花眼治疗市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Ziemer Ophthalmic Systems AG
  • NIDEK CO., LTD.
  • Johnson & Johnson Vision
  • EssilorLuxottica.
  • ZEISS Group
  • Alcon Vision LLC
  • Bausch+Lomb Corporation
  • Haag-Streit UK
  • Topcon Corporation

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 20933

The Global Myopia And Presbyopia Treatment Market is projected to expand significantly, growing from USD 21.95 Billion in 2025 to USD 35.38 Billion by 2031, reflecting a compound annual growth rate of 8.28%. This industry encompasses a broad range of corrective medical solutions, including prescription eyeglasses, contact lenses, refractive surgeries, and pharmacological agents designed to rectify nearsightedness and age-related vision loss. The sector's growth is primarily fueled by demographic shifts, such as an aging global population, and the rising prevalence of myopia linked to lifestyle factors like increased digital consumption and reduced outdoor activity. Additionally, a strong latent consumer demand for spectacle independence serves as a powerful catalyst for adopting modern corrective technologies; for instance, 2024 data from the Contact Lens Institute indicated that 47.8 percent of glasses wearers who had never tried contact lenses were highly interested in doing so, revealing a substantial opportunity for market penetration.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 21.95 Billion
Market Size 2031USD 35.38 Billion
CAGR 2026-20318.28%
Fastest Growing SegmentPrescription
Largest MarketNorth America

However, the market faces a significant hurdle regarding the prohibitive cost and limited accessibility of advanced corrective procedures, particularly in emerging economies. The substantial financial investment required for premium refractive surgeries and specialized management devices restricts their adoption largely to wealthier demographics, thereby slowing growth in developing regions where healthcare infrastructure is less established. Consequently, while demand exists, economic barriers prevent broader expansion in these markets.

Market Driver

The escalating global prevalence of myopia and presbyopia is fundamentally reshaping the treatment landscape and serving as a primary catalyst for market growth. This surge is increasingly connected to lifestyle factors such as rapid urbanization and intense digital consumption, which have accelerated the onset of refractive errors in younger demographics. As a result, there is a heightened urgency for effective management strategies that go beyond traditional corrective eyewear, driving the adoption of specialized control lenses and interventions. Underscoring this critical public health challenge, the Association of Optometrists reported in their October 2024 article, 'Examining the global prevalence of myopia,' that researchers estimated the current global prevalence of myopia among children and young people to be 30.47%, a figure that is compelling manufacturers to innovate rapidly.

Concurrently, the emergence of novel pharmacological therapies and corrective eye drops is revolutionizing patient care by offering non-invasive alternatives to surgery and spectacles. Recent commercial launches of presbyopia-correcting drops and low-dose atropine for myopia indicate a significant shift toward pharmaceutical management of vision impairment, supported by substantial capital inflows aimed at commercializing these solutions. For example, Optometry Times reported in October 2024 that Orasis Pharmaceuticals secured $78 million in financing to support the commercial launch of Qlosi. This robust investment climate highlights the sector's financial vitality, further evidenced by The Vision Council's report that the U.S. optical industry achieved a total market value of $68.3 billion in 2024.

Market Challenge

The prohibitive cost and limited accessibility of advanced corrective procedures constitute a primary obstruction to the expansion of the global market. High financial barriers associated with premium refractive surgeries and specialized pharmacological agents effectively restrict the adoption of these solutions to affluent demographics. This economic stratification prevents the mass market, particularly in developing nations, from transitioning away from traditional, lower-cost correctives like standard eyeglasses. Consequently, the addressable market size is artificially capped, as a vast majority of the patient population cannot afford the significant out-of-pocket leverage required for modern interventions, despite the clinical benefits they offer.

This challenge is exacerbated by the substantial price tag attached to elective procedures, which often lack comprehensive insurance coverage. According to the Refractive Surgery Council, in 2024, the average cost of LASIK eye surgery was approximately $4,400 for a bilateral procedure. Such a high price point is prohibitive in emerging economies where disposable income is limited and healthcare infrastructure is often insufficient to support widespread access to such specialized treatments. As a result, market penetration in these high-growth potential regions remains sluggish, hampering the overall revenue trajectory of the industry.

Market Trends

The proliferation of next-generation myopia control spectacle lenses is establishing a new standard of care for pediatric patients, moving beyond traditional single-vision correction. These advanced lenses utilize specialized optical defocus technologies to actively slow eyeball elongation, contrasting with standard glasses that merely correct refractive error. This shift is driven by clinical evidence of their efficacy, prompting adoption as a primary non-invasive intervention. The commercial success of these products highlights their growing importance in the treatment mix; according to EssilorLuxottica's 'Q4/Full Year 2024 Results' press release in February 2025, revenue for Stellest lenses increased by approximately 50% in China during the fourth quarter.

Advancements in Implantable Collamer Lens (ICL) technologies are simultaneously expanding surgical options for high myopia patients often unsuitable for corneal laser procedures. This reflects a technological pivot from subtractive techniques like LASIK to additive solutions that preserve corneal integrity. Manufacturers are enhancing these devices with wider refractive ranges, increasing surgeon confidence and patient acceptance. This segment is witnessing robust financial performance as procedure volumes rise; according to the 'STAAR Surgical Announces Preliminary Net Sales Results for Third Quarter 2025' press release in October 2025, the company reported preliminary net sales of $94.7 million, representing a 6.9% increase compared to the prior year period.

Key Market Players

  • Ziemer Ophthalmic Systems AG
  • NIDEK CO., LTD.
  • Johnson & Johnson Vision
  • EssilorLuxottica.
  • ZEISS Group
  • Alcon Vision LLC
  • Bausch + Lomb Corporation
  • Haag-Streit UK
  • Topcon Corporation

Report Scope

In this report, the Global Myopia And Presbyopia Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Myopia And Presbyopia Treatment Market, By Myopia Treatment Type

  • Corrective
  • Surgical
  • Drugs

Myopia And Presbyopia Treatment Market, By Presbyopia Treatment Type

  • Prescription
  • Contact Lenses
  • Intraocular Lenses
  • Refractive Surgery

Myopia And Presbyopia Treatment Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Myopia And Presbyopia Treatment Market.

Available Customizations:

Global Myopia And Presbyopia Treatment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Myopia And Presbyopia Treatment Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Myopia Treatment Type (Corrective, Surgical, Drugs)
    • 5.2.2. By Presbyopia Treatment Type (Prescription, Contact Lenses, Intraocular Lenses, Refractive Surgery)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Myopia And Presbyopia Treatment Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Myopia Treatment Type
    • 6.2.2. By Presbyopia Treatment Type
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Myopia And Presbyopia Treatment Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Myopia Treatment Type
        • 6.3.1.2.2. By Presbyopia Treatment Type
    • 6.3.2. Canada Myopia And Presbyopia Treatment Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Myopia Treatment Type
        • 6.3.2.2.2. By Presbyopia Treatment Type
    • 6.3.3. Mexico Myopia And Presbyopia Treatment Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Myopia Treatment Type
        • 6.3.3.2.2. By Presbyopia Treatment Type

7. Europe Myopia And Presbyopia Treatment Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Myopia Treatment Type
    • 7.2.2. By Presbyopia Treatment Type
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Myopia And Presbyopia Treatment Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Myopia Treatment Type
        • 7.3.1.2.2. By Presbyopia Treatment Type
    • 7.3.2. France Myopia And Presbyopia Treatment Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Myopia Treatment Type
        • 7.3.2.2.2. By Presbyopia Treatment Type
    • 7.3.3. United Kingdom Myopia And Presbyopia Treatment Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Myopia Treatment Type
        • 7.3.3.2.2. By Presbyopia Treatment Type
    • 7.3.4. Italy Myopia And Presbyopia Treatment Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Myopia Treatment Type
        • 7.3.4.2.2. By Presbyopia Treatment Type
    • 7.3.5. Spain Myopia And Presbyopia Treatment Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Myopia Treatment Type
        • 7.3.5.2.2. By Presbyopia Treatment Type

8. Asia Pacific Myopia And Presbyopia Treatment Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Myopia Treatment Type
    • 8.2.2. By Presbyopia Treatment Type
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Myopia And Presbyopia Treatment Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Myopia Treatment Type
        • 8.3.1.2.2. By Presbyopia Treatment Type
    • 8.3.2. India Myopia And Presbyopia Treatment Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Myopia Treatment Type
        • 8.3.2.2.2. By Presbyopia Treatment Type
    • 8.3.3. Japan Myopia And Presbyopia Treatment Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Myopia Treatment Type
        • 8.3.3.2.2. By Presbyopia Treatment Type
    • 8.3.4. South Korea Myopia And Presbyopia Treatment Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Myopia Treatment Type
        • 8.3.4.2.2. By Presbyopia Treatment Type
    • 8.3.5. Australia Myopia And Presbyopia Treatment Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Myopia Treatment Type
        • 8.3.5.2.2. By Presbyopia Treatment Type

9. Middle East & Africa Myopia And Presbyopia Treatment Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Myopia Treatment Type
    • 9.2.2. By Presbyopia Treatment Type
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Myopia And Presbyopia Treatment Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Myopia Treatment Type
        • 9.3.1.2.2. By Presbyopia Treatment Type
    • 9.3.2. UAE Myopia And Presbyopia Treatment Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Myopia Treatment Type
        • 9.3.2.2.2. By Presbyopia Treatment Type
    • 9.3.3. South Africa Myopia And Presbyopia Treatment Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Myopia Treatment Type
        • 9.3.3.2.2. By Presbyopia Treatment Type

10. South America Myopia And Presbyopia Treatment Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Myopia Treatment Type
    • 10.2.2. By Presbyopia Treatment Type
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Myopia And Presbyopia Treatment Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Myopia Treatment Type
        • 10.3.1.2.2. By Presbyopia Treatment Type
    • 10.3.2. Colombia Myopia And Presbyopia Treatment Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Myopia Treatment Type
        • 10.3.2.2.2. By Presbyopia Treatment Type
    • 10.3.3. Argentina Myopia And Presbyopia Treatment Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Myopia Treatment Type
        • 10.3.3.2.2. By Presbyopia Treatment Type

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Myopia And Presbyopia Treatment Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Ziemer Ophthalmic Systems AG
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. NIDEK CO., LTD.
  • 15.3. Johnson & Johnson Vision
  • 15.4. EssilorLuxottica.
  • 15.5. ZEISS Group
  • 15.6. Alcon Vision LLC
  • 15.7. Bausch + Lomb Corporation
  • 15.8. Haag-Streit UK
  • 15.9. Topcon Corporation

16. Strategic Recommendations

17. About Us & Disclaimer